Literature DB >> 2170945

Selection against CpG dinucleotides in lentiviral genes: a possible role of methylation in regulation of viral expression.

E G Shpaer1, J I Mullins.   

Abstract

Extremely low frequencies of CpG dinucleotides are found in the genomes of the lentivirus subfamily of retroviruses, including the human, simian and feline immunodeficiency viruses (HIV1, HIV2, SIV, and FIV, respectively), equine infectious anemia virus (EIAV), and the ovine lentivirus, Visna. The occurrence of CpG dinucleotides is greater in the 2-3 (NCG) than in the 1-2 (CGN) codon-defined frame, as well as in the gag and env genes, compared to the more conserved pol gene. These differences suggest that CpG depletion in lentiviruses occurs as a result of selection against CpG rather than due to mutational bias, the latter is responsible for low CpG frequencies in vertebrate genomes. CpG levels in the onco-retrovirus subfamily are reduced to a lesser extent, principally due to mutational bias. The difference between the retrovirus subfamilies appears to reflect their evolutionary origin, that is, lentiviruses have no known endogenous counterparts whereas most oncoviruses have endogenous cellular counterparts with which they can undergo recombination. Furthermore, we suggest that the number of CpG dinucleotides in a lentiviral genome determines the maximum potential DNA methylation level of the provirus, which in turn affects viral transcription in host cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170945      PMCID: PMC332316          DOI: 10.1093/nar/18.19.5793

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  29 in total

1.  Genetic recombinants and heterozygotes derived from endogenous and exogenous avian RNA tumor viruses.

Authors:  R A Weiss; W S Mason; P K Vogt
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

2.  Independent mechanisms involved in suppression of the Moloney leukemia virus genome during differentiation of murine teratocarcinoma cells.

Authors:  O Niwa; Y Yokota; H Ishida; T Sugahara
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

3.  Delayed de novo methylation in teratocarcinoma suggests additional tissue-specific mechanisms for controlling gene expression.

Authors:  J W Gautsch; M C Wilson
Journal:  Nature       Date:  1983-01-06       Impact factor: 49.962

4.  Clusters of CpG dinucleotides implicated by nuclease hypersensitivity as control elements of housekeeping genes.

Authors:  S F Wolf; B R Migeon
Journal:  Nature       Date:  1985 Apr 4-10       Impact factor: 49.962

5.  DNA methylation and the frequency of CpG in animal DNA.

Authors:  A P Bird
Journal:  Nucleic Acids Res       Date:  1980-04-11       Impact factor: 16.971

6.  Asymmetrical distribution of CpG in an 'average' mammalian gene.

Authors:  M McClelland; R Ivarie
Journal:  Nucleic Acids Res       Date:  1982-12-11       Impact factor: 16.971

Review 7.  Eukaryotic DNA methylation.

Authors:  D N Cooper
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

8.  DNA methylation affecting the expression of murine leukemia proviruses.

Authors:  J W Hoffmann; D Steffen; J Gusella; C Tabin; S Bird; D Cowing; R A Weinberg
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

9.  Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14.

Authors:  S Dewhurst; J E Embretson; D C Anderson; J I Mullins; P N Fultz
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

10.  Regulation of viral and cellular oncogene expression by cytosine methylation.

Authors:  J Groffen; N Heisterkamp; G Blennerhassett; J R Stephenson
Journal:  Virology       Date:  1983-04-15       Impact factor: 3.616

View more
  20 in total

Review 1.  Signal transduction induced by immunostimulatory CpG DNA.

Authors:  A M Krieg
Journal:  Springer Semin Immunopathol       Date:  2000

2.  Distinctive features of large complex virus genomes and proteomes.

Authors:  Jan Mrázek; Samuel Karlin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-09       Impact factor: 11.205

Review 3.  Biological aspects of cytosine methylation in eukaryotic cells.

Authors:  M Hergersberg
Journal:  Experientia       Date:  1991-12-01

Review 4.  Models of coding sequence evolution.

Authors:  Wayne Delport; Konrad Scheffler; Cathal Seoighe
Journal:  Brief Bioinform       Date:  2008-10-29       Impact factor: 11.622

5.  Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs.

Authors:  A M Krieg; T Wu; R Weeratna; S M Efler; L Love-Homan; L Yang; A K Yi; D Short; H L Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

6.  Nucleotide composition as a driving force in the evolution of retroviruses.

Authors:  E C Bronson; J N Anderson
Journal:  J Mol Evol       Date:  1994-05       Impact factor: 2.395

7.  The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins.

Authors:  B Berkhout; F J van Hemert
Journal:  Nucleic Acids Res       Date:  1994-05-11       Impact factor: 16.971

8.  Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses?

Authors:  S Karlin; W Doerfler; L R Cardon
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

9.  Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.

Authors:  Andrew E Armitage; Koen Deforche; John J Welch; Kristel Van Laethem; Ricardo Camacho; Andrew Rambaut; Astrid K N Iversen
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

10.  Transcriptional suppression of in vitro-integrated human immunodeficiency virus type 1 does not correlate with proviral DNA methylation.

Authors:  Marjorie Pion; Albert Jordan; Angelique Biancotto; Franck Dequiedt; Françoise Gondois-Rey; Sophie Rondeau; Robert Vigne; Jiri Hejnar; Eric Verdin; Ivan Hirsch
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.